CULVER CITY, Calif.–(BUSINESS WIRE)–ImmunityBio, Inc., a privately-held immunotherapy company, today announced that it has appointed Fabio M. Benedetti, M.D., as Chief Strategy Officer, effective January 4, 2021. Dr. Benedetti brings more than 20 yea… […]
Amgen scored a big pickup with its acquisition of immunology blockbuster Otezla from Bristol Myers Squibb late last year. But that deal also came with a molecule for tuberculosis and leprosy with significantly less commercial value, and Amgen is ready … […]
Amgen scored a big pickup with its acquisition of immunology blockbuster Otezla from Bristol Myers Squibb late last year. But that deal also came with a molecule for tuberculosis and leprosy with significantly less commercial value, and Amgen is ready … […]
Once flush with partners for heart failure drug omecamtiv mecarbil, Cytokinetics watched its longtime ally Amgen flee last month over weak data from a Phase III trial. Now, Cytokinetics’ last running mate is hitting the exit — leaving omecamtiv on an u… […]
Once flush with partners for heart failure drug omecamtiv mecarbil, Cytokinetics watched its longtime ally Amgen flee last month over weak data from a Phase III trial. Now, Cytokinetics’ last running mate is hitting the exit — leaving omecamtiv on an u… […]
→ John Maraganore is closing out the year with a surge of new hires at Alnylam just a month after lumasiran notched an FDA approval for primary hyperoxaluria type 1 (PH1). Tolga Tanguler, who takes on the role of chief commercial officer, has Big Pharm… […]
IRVINE, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) — Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients undergoing organ or cellular transpla… […]
LOS ANGELES–(BUSINESS WIRE)–XPRIZE, a nonprofit organization that uses global competitions to crowdsource solutions to some of the world’s biggest challenges, is pleased to announce that, following last week’s pitch slam, Luminosity Lab from the Unit… […]
LOS ANGELES–(BUSINESS WIRE)–Purlab, the at-home saliva-based COVID-19 testing solution for individuals, companies and schools, created to make testing easy and accessible, has launched. The robust proprietary technology allows for a user-friendly pro… […]
LOS ANGELES–(BUSINESS WIRE)–XPRIZE, the world’s leader in designing and operating incentive competitions to solve humanity’s grand challenges, today announced the 20 finalist teams advancing in the $6 million XPRIZE Rapid Covid Testing prize, a compe… […]
Copyright © 2021 Biotech Networks, LLC
